Vitamin D receptor ligands: the impact of crystal structures

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Therapeutic Patents

• Publication date

  2012-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1517/13543776.2012.673590PMID 22449247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current status of vitamin D signaling and its therapeutic applications.

  2012cited by this paper
• 1α,25(OH)2-3-Epi-Vitamin D3, a Natural Physiological Metabolite of Vitamin D3: Its Synthesis, Biological Activity and Crystal Structure with Its Receptor

  2011cited by this paper
• New C15-substituted active vitamin D3.

  2011cited by this paper
• Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1α-hydroxy-19-norvitamin D analogues with shortened alkyl side chains.

  2011cited by this paper
• Why the IOM recommendations for vitamin D are deficient

  2011cited by this paper
• Boron cluster-based development of potent nonsecosteroidal vitamin D receptor ligands: direct observation of hydrophobic interaction between protein surface and carborane.

  2011influential reference
• Synthesis, Structure, and Biological Activity of des‐Side Chain Analogues of 1α,25‐Dihydroxyvitamin D3 with Substituents at C18

  2011cited by this paper
• Structural Basis for Ligand Activity in VDR

  2011cited by this paper
• Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor.

  2011cited by this paper
• 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.

  2010cited by this paper
• Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3.

  2010cited by this paper
• Synthesis and biological evaluation of 6-methyl analog of 1alpha,25-dihydroxyvitamin D3.

  2010cited by this paper
• Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone.

  2010cited by this paper
• Vitamin D: a pleiotropic hormone.

  2010cited by this paper
• CD-ring modified vitamin D3 analogs and their superagonistic action.

  2010cited by this paper
• An expeditious route to 1alpha,25-dihydroxyvitamin D(3) and its analogues by an aqueous tandem palladium-catalyzed a-ring closure and suzuki coupling to the C/D unit.

  2010cited by this paper
• An o-aminoanilide analogue of 1α,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist.

  2010cited by this paper
• A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.

  2009influential reference
• Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.

  2009cited by this paper
• Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.

  2008cited by this paper
• Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301.

  2008cited by this paper
• Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.

  2008cited by this paper
• Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor.

  2008cited by this paper
• Calcium and phosphate homeostasis: Concerted interplay of new regulators

  2008cited by this paper
• Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1alpha,25-(OH)2D3.

  2007cited by this paper
• 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.

  2007cited by this paper
• Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.

  2007cited by this paper
• Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3).

  2007cited by this paper
• Design, Synthesis, and Biological Evaluation of a 1α,25-Dihydroxy-19-norvitamin D3 Analogue with a Frozen A-Ring Conformation

  2007cited by this paper
• Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation.

  2007cited by this paper
• Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1α,25-(OH)2D3

  2007cited by this paper
• The development of CD-ring modified analogs of 1alpha,25-dihydroxyvitamin D.

  2007cited by this paper
• Selective analogs of 1α,25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D

  2007cited by this paper
• Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition.

  2007cited by this paper
• Creative synthesis of novel vitamin D analogs for health and disease.

  2007cited by this paper
• Novel 1α,25-Dihydroxyvitamin D3 Analogues with the Side Chain at C12

  2006cited by this paper
• Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2α-functionalization of 25 -dehydro -1α -hydroxyvitamin D3-26,23-lactones

  2006cited by this paper
• Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands.

  2006cited by this paper
• Anticancer effects of the novel 1α, 25‐dihydroxyvitamin D3 hybrid analog QW1624F2‐2 in human neuroblastoma

  2006cited by this paper
• Convergence of vitamin D and retinoic acid signalling at a common hormone response element

  2006cited by this paper
• New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.

  2006cited by this paper
• Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.

  2006cited by this paper
• Vitamin D receptor: ligand recognition and allosteric network.

  2006cited by this paper
• Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.

  2006cited by this paper
• Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.

  2006influential reference
• Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.

  2006cited by this paper
• Gene regulatory potential of nonsteroidal vitamin D receptor ligands.

  2005cited by this paper
• Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs.

  2005cited by this paper
• 2-alkylidene 18,19-dinor - vitamin d compounds

  2005cited by this paper
• Low-calcemic, efficacious, 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry.

  2004cited by this paper
• Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.

  2004cited by this paper
• Predicting the cell differentiation activity of 1 alpha,25-dihydroxyvitamin D3 side chain analogues from docking simulations.

  2004cited by this paper
• A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.

  2004influential reference
• Overview of general physiologic features and functions of vitamin D.

  2004cited by this paper
• Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs.

  2003cited by this paper
• Previtamin D3 with a trans-Fused Decalin CD-ring Has Pronounced Genomic Activity*

  2003cited by this paper
• Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.

  2003cited by this paper
• Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.

  2003cited by this paper
• Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators.

  2003cited by this paper
• Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

  2003cited by this paper
• Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones.

  2003cited by this paper
• The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.

  2003cited by this paper
• Molecular basis of the selective activity of vitamin D analogues

  2003cited by this paper
• Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs.

  2003cited by this paper
• New vitamin D receptor ligands

  2003cited by this paper
• A new active vitamin D analog, ED‐71, causes increase in bone mass with preferential effects on bone in osteoporotic patients

  2003cited by this paper
• Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets.

  2002cited by this paper
• Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.

  2002cited by this paper
• Structure-based design of selective agonists for a rickets-associated mutant of the vitamin d receptor.

  2002cited by this paper
• Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets.

  2002cited by this paper
• Vitamin D(3): synthesis of seco-C-9,11-bisnor-17-methyl-1 alpha,25-dihydroxyvitamin D(3) analogues.

  2002cited by this paper
• Different molecular mechanisms of vitamin D(3) receptor antagonists.

  2001cited by this paper
• The practical synthesis of vitamin D analogs: a challenge for process research.

  2001cited by this paper
• Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands

  2001cited by this paper
• The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.

  2000cited by this paper
• Structure activity relationship of carboxylic ester antagonists of the vitamin D(3) receptor.

  2000cited by this paper
• Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions.

  2000influential reference
• 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.

  2000cited by this paper
• Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.

  2000cited by this paper
• Antagonistic Action of a 25-Carboxylic Ester Analogue of 1α,25-Dihydroxyvitamin D3 Is Mediated by a Lack of Ligand-induced Vitamin D Receptor Interaction with Coactivators*

  2000cited by this paper
• Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens.

  1999cited by this paper
• Vitamin D resistance.

  1999influential reference
• Analysis of the Molecular Mechanism for the Antagonistic Action of a Novel 1α,25-Dihydroxyvitamin D3 Analogue toward Vitamin D Receptor Function*

  1999cited by this paper
• Vitamin D3 mimics of

  1999cited by this paper
• Antagonistic Action of Novel 1α,25-Dihydroxyvitamin D3-26,23-lactone Analogs on Differentiation of Human Leukemia Cells (HL-60) Induced by 1α,25-Dihydroxyvitamin D3 *

  1999cited by this paper
• Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.

  1999cited by this paper
• 1α,25‐Dihydroxyvitamin D3‐26,23‐lactone analogs antagonize differentiation of human leukemia cells (HL‐60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells)

  1999cited by this paper
• Receptors for 1α,25(OH)2D3: Past, Present, and Future

  1998cited by this paper
• Receptors for 1alpha,25(OH)2D3: past, present, and future.

  1998cited by this paper
• The Biological Activity of Nonsteroidal Vitamin D Hormone Analogs Lacking Both the C‐ and D‐Rings

  1998cited by this paper
• Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling.

  1995cited by this paper
• Structure-function relationships in the vitamin D endocrine system.

  1995cited by this paper
• New Strategies for the Synthesis of Vitamin D Metabolites via Pd‐ Catalyzed Reactions.

  1993cited by this paper
• Structure function analysis of vitamin D analogs with C-ring modifications.

  1992cited by this paper
• New strategies for the synthesis of vitamin D metabolites via palladium-catalyzed reactions

  1992cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper

• Design, synthesis, and anti-liver fibrosis activity of novel non-steroidal vitamin D receptor agonists based on open-ring steroid scaffold.

  2025cites this paper
• Association between vitamin D receptor polymorphisms and diabetic retinopathy in Uygur Chinese with type 2 diabetes

  2025cites this paper
• First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity.

  2024cites this paper
• Genomic signaling of vitaminD.

  2023cites this paper
• The fine crosstalk between vitamin D and pituitary gland

  2023cites this paper
• Design, synthesis and anti-hepatic fibrosis activity of novel diphenyl vitamin D receptor agonists.

  2023cites this paper
• A biologically-inspired multi-modal evaluation of molecular generative machine learning

  2022cites this paper
• Deciphering the importance of MD descriptors in designing Vitamin D Receptor agonists and antagonists using machine learning.

  2022cites this paper
• Design, Synthesis, Biological Activity, and Structural Analysis of Novel Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D3.

  2022cites this paper
• A biologically-inspired evaluation of molecular generative machine learning

  2022cites this paper
• Design, Synthesis, Evaluation and Structure of Allenic 1α,25‐Dihydroxyvitamin D3 Analogs with Locked Mobility at C‐17

  2021cites this paper
• Novel superagonist analogs of 2-methylene calcitriol: Design, molecular docking, synthesis and biological evaluation.

  2021cites this paper
• Vitamin D3 alleviates cognitive impairment through regulating inflammatory stress in db/db mice

  2021influential citation
• Mechanism of Vitamin D Receptor Ligand-Binding Domain Regulation Studied by gREST Simulations

  2021cites this paper
• Vitamin D and its analogs as anticancer and anti-inflammatory agents.

  2020cites this paper
• New aspects of vitamin D metabolism and action — addressing the skin as source and target

  2020cites this paper
• Vitamin D receptor(s): In the nucleus but also at membranes?

  2020cites this paper
• Novel calcitriol analogue with an oxolane group: In vitro, in vivo, and in silico studies

  2019cites this paper
• Synthesis of 19-norcalcitriol analogs with pegylated alkylidene chains at C-2.

  2019cites this paper
• Vitamin D and Its Synthetic Analogs

  2019cites this paper
• Vitamins, 3. Vitamin D

  2019cites this paper
• Structural Basis for Ligand Activity in Vitamin D Receptor

  2018cites this paper
• Synthesis of Side-Chain Locked Analogs of 1α,25-Dihydroxyvitamin D3 Bearing a C17 Methyl Group.

  2018cites this paper
• Synthesis of 19-norcalcitriol analogs with alkylidene moieties at C-2 based on succinic acid and l-methionine.

  2017cites this paper
• Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.

  2017cites this paper
• Synthesis of A‐Ring Precursors of 1α,25‐Dihydroxyvitamin D3 Analogues Functionalized at C‐2

  2017cites this paper
• Regulation of the vitamin D receptor by vitamin D lactam derivatives

  2016cites this paper
• Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.

  2016cites this paper
• Vitamin D receptor 2016: novel ligands and structural insights

  2016cites this paper
• The vitamin D-dependent transcriptome of human monocytes.

  2016cites this paper
• Molecular Approaches for Optimizing Vitamin D Supplementation.

  2016cites this paper
• Ligand-Independent Actions of Vitamin D Receptor

  2016cites this paper
• Etude de la dynamique structurale du domaine de liaison au ligand de RXRα et implication de la phosphorylation dans la transcription

  2016cites this paper
• Structural development of stapled short helical peptides as vitamin D receptor (VDR)-coactivator interaction inhibitors.

  2015cites this paper
• Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view.

  2015cites this paper
• Predicted structures of new Vitamin D Receptor agonists based on available X-ray structures.

  2015cites this paper
• Synthesis and biological activity of two C-7 methyl analogues of vitamin D.

  2015cites this paper
• Therapeutic application of vitamin D receptor ligands: an updated patent review

  2015cites this paper
• Double point modified analogs of vitamin d as potent activators of vitamin D receptor.

  2015cites this paper
• Structural insights into the molecular mechanism of vitamin D receptor activation by lithocholic acid involving a new mode of ligand recognition.

  2014cites this paper
• Phosphonate analogues of 1α, 25 dihydroxyvitamin D3 are promising candidates for antitumoural therapies.

  2014cites this paper
• Retinoic acid actions through mammalian nuclear receptors.

  2014cites this paper
• Modulators of vitamin D nuclear receptor: recent advances from structural studies.

  2014cites this paper
• Modulation of Transcription mediated by the Vitamin D Receptor and the Peroxisome Proliferator-Activated Receptor δ in the presence of GW0742 analogs.

  2014cites this paper
• IDENTIFICATION OF VDR ANTAGONISTS AMONG NUCLEAR RECEPTOR LIGANDS USING VIRTUAL SCREENING.

  2014cites this paper
• Structural considerations of vitamin D signaling

  2014cites this paper
• Functionalization of non-activated C-H bonds in the synthesis of vitamin D metabolites and analogs.

  2014cites this paper
• Development of stapled short helical peptides capable of inhibiting vitamin D receptor (VDR)-coactivator interactions.

  2013cites this paper
• Structural basis for vitamin D receptor agonism by novel non‐secosteroidal ligands

  2013cites this paper
• 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR.

  2013cites this paper
• Analogues of the Inhoffen-Lythgoe diol with anti-proliferative activity.

  2013cites this paper
• 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in vivo.

  2013cites this paper
• Peroxisome proliferation-activated receptor δ agonist GW0742 interacts weakly with multiple nuclear receptors, including the vitamin D receptor.

  2013cites this paper
• Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks

  2013cites this paper
• Synthesis of (1α)-1,25-Dihydroxyvitamin D3 with a β-Positioned Seven-Carbon Side Chain at C(12)

  2012cites this paper
• Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.

  2012cites this paper
• VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation

  2012cites this paper
• Cyclical regulation of the insulin-like growth factor binding protein 3 gene in response to 1α,25-dihydroxyvitamin D3

  2010cites this paper
• SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications

  2005cites this paper
• Vitamin D receptor signaling and its therapeutic implications : Genome-wide and structural view 1

  year unknowncites this paper